Overexpression or knockdown of LINC00473/KMT5A by transfection of specific pcDNA 3.1 (+) or small interfering RNA (siRNA), overexpression, or inhibition of miR-502-3p by transfection of miR-502-3p-mimic or inhibitor, all reagents were purchased from Guangzhou RIOBIO Biotechnology Co., Ltd (RIOBIO, Guangzhou, China). Cells were transfected with Lipofectamine 2000 (Invitrogen, CA, USA), and the transfection efficiency was evaluated by qRT-PCR.
Copyright and License information: The Author(s) ©2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.